Skip to content

Vaxcyte, Inc. PCVX Current ratio

Current ratio at other companies

Pfizer logo
PfizerPFE
1.2×0.0×
Merck & Co. logo
Merck & Co.MRK
1.3×-0.1×
Moderna logo
ModernaMRNA
2.4×-1.8×
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
9.5×-0.2×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
6.7×+4.4×
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
+0.4×

Other financials

Income statement

See full
Operating income-$345.9M-91.3%
Net income-$320.6M-128%
EPS (diluted)-$2.30-121%

Balance sheet

See full
Cash & equivalents$262.3M-24.7%
Total debt$116.3M+33.5%
Total equity$3.0B-6.4%
Total assets$3.3B-0.9%

Cash flow

See full
Operating cash flow-$280.6M-68.8%
CapEx$2.1M-61.2%
Free cash flow-$282.7M-64.7%

Valuation

See full
Market cap$7.43B+72.0%
Enterprise value$7.28B+78.6%

Returns & leverage

See full
Return on equity-30.6%+37.9pp
Debt / equity0.0×

Where this comes from

Calculated from Vaxcyte, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vaxcyte, Inc.'s current ratio?
Vaxcyte, Inc. (PCVX) reported current ratio of 7.5× in Q1 2026.
How has Vaxcyte, Inc.'s current ratio changed year-over-year?
Vaxcyte, Inc.'s current ratio decreased by 57.7% year-over-year, from 17.7× to 7.5×.
What is the long-term trend for Vaxcyte, Inc.'s current ratio?
Over 5 years (2020 to 2025), Vaxcyte, Inc.'s current ratio has grown at a -1.0% compound annual growth rate (CAGR), from 8.3× to 7.9×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.